Eating Disorders Genetics Initiative

NCT04378101 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17991

Last updated 2023-06-06

No results posted yet for this study

Summary

The overarching intention of the Eating Disorder Genetics Initiative (EDGI) is to lay the foundation for all future genomic discovery in eating disorders--anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED)--by exploring both genetic and behavioral factors. To do this, information will be collected from 4000 people who have provided DNA samples for the Anorexia Nervosa Genetics Initiative (ANGI) and the same information and DNA will be collected from an additional 16,000 people. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.

Conditions

  • Anorexia Nervosa
  • Bulimia Nervosa
  • Binge-Eating Disorder

Interventions

OTHER

Eating disorder diagnosis group

This is an observational study, no active intervention is applied. Participants are assigned to an eating disorder diagnosis group based on their lifetime history of disordered eating behaviors and symptoms.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • University of Otago

    collaborator OTHER
  • University of Aarhus

    collaborator OTHER
  • QIMR Berghofer Medical Research Institute

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Cynthia M Bulik, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
15 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • United States
  • Australia
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04378101 on ClinicalTrials.gov